Risk of common infections among individuals with psoriasis in Sweden: A nationwide cohort study comparing secukinumab to ustekinumab.

Chaitra SrinivasIngvild OdsbuMarie Linder

Published in: Pharmacoepidemiology and drug safety (2020)

We observed a slightly increased risk of respiratory and urinary tract infections treated in primary care among secukinumab users compared to ustekinumab users. Larger studies with longer follow-up are needed to draw conclusions on relative safety.

Keyphrases

urinary tract infection
primary care
ankylosing spondylitis
rheumatoid arthritis
disease activity
general practice
newly diagnosed